FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
The Canadian veterinary journal = La revue veterinaire canadienne2015; 56(6); 575-580;

Seroprevalence of equine granulocytic anaplasmosis and lyme borreliosis in Canada as determined by a point-of-care enzyme-linked immunosorbent assay (ELISA).

Abstract: Equine granulocytic anaplasmosis (EGA) and Lyme borreliosis (LB) are an emerging concern in Canada. We estimated the seroprevalence of EGA and equine LB by testing 376 convenience serum samples from 3 provinces using a point-of-care SNAP(®) 4Dx(®) ELISA (IDEXX Laboratories, Westbrook, Maine, USA), and investigated the agreement between the point-of-care ELISA and laboratory-based serologic tests. The estimated seroprevalence for EGA was 0.53% overall (0.49% in Saskatchewan, 0.71% in Manitoba), while the estimated seroprevalence for LB was 1.6% overall (0.49% in Saskatchewan, 2.86% in Manitoba). There was limited agreement between the point-of-care ELISA and an indirect fluorescent antibody test for EGA (kappa 0.1, PABAK 0.47) and an ELISA/Western blot combination for LB (kappa 0.23, PABAK 0.71). While the SNAP(®) 4Dx(®) ELISA yielded expected seroprevalence estimates, further evaluation of serologic tests for the purposes of disease exposure recognition may be needed. Séroprévalence de l’anaplasmose granulocytaire équine et de la borréliose de Lyme au Canada telle que déterminée par un test ELISA hors laboratoire. L’anaplasmose granulocytaire équine (AGE) et la borréliose de Lyme (BL) sont de nouvelles maladies émergentes au Canada. Nous avons estimé la séroprévalence de l’AGE et de la BL équine en testant 376 échantillons sériques de commodité provenant de trois provinces en utilisant un test ELISA SNAPMD 4DxMD hors laboratoire (IDEXX Laboratories, Westbrook, Maine, États-Unis) et nous avons analysé la concordance entre les tests ELISA hors laboratoire et des tests sérologiques faits en laboratoire. Le total des séroprévalences estimées pour l’AGE était de 0,53 % (0,49 % en Saskatchewan, 0,71 % au Manitoba), tandis que le total de la séroprévalence estimée de BL était de 1,6 % (0,49 % en Saskatchewan, 2,86 % au Manitoba). Il y avait une concordance limitée entre le test ELISA hors laboratoire et un test d’immunofluorescence indirecte pour l’AGE (kappa 0,1, PABAK 0,47) et une combinaison de tests ELISA/immunobuvardage pour BL (kappa 0,23, PABAK 0,71). Même si le test ELISA SNAPMD 4DxMD hors laboratoire a donné des estimations de séroprévalence attendues, une nouvelle évaluation des tests sérologiques à des fins de reconnaissance de l’exposition à une maladie peut être requise.(Traduit par Isabelle Vallières).
Get Full Text
Publication Date: 2015-06-02 PubMed ID: 26028677PubMed Central: PMC4431153
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study is looking at the prevalence of Equine Granulocytic Anaplasmosis (EGA) and Lyme borreliosis (LB) in horses in three provinces in Canada. It used a point-of care ELISA test to assess a convenience sample of horse blood serum and compared the results with laboratory-based blood tests.

Background

  • The researchers are interested in EGA and LB, diseases that are emerging concerns in Canada.
  • These diseases affect horses and can have serious implications for animal health.
  • To learn more about the extent of these diseases, the goal of the study was to estimate the seroprevalence (the level of a pathogen in a population, as measured in blood serum) of EGA and LB in horses from three provinces in Canada.

Methodology

  • The researchers used serum samples from horses and tested them using a point-of-care ELISA (enzyme-linked immunosorbent assay) test, specifically the SNAP® 4Dx® ELISA developed by IDEXX Laboratories.
  • The ELISA test allowed for quick and easy testing on the spot, compared with laboratory-based tests which tend to be more time-consuming and expensive.
  • The results from the point-of-care ELISA tests were compared with results from more traditional, laboratory-based serologic tests to evaluate the agreement between these methods.

Findings

  • The estimated seroprevalence for EGA was found to be 0.53% overall, with slight differences between provinces.
  • The estimated seroprevalence for LB was higher, at 1.6% overall, again with some differences between provinces.
  • When compared with the lab-based tests, there was limited agreement with the ELISA results for both diseases.

Implications

  • The SNAP® 4Dx® ELISA did provide expected seroprevalence estimates, but the limited agreement with lab-based tests indicates that further evaluation might be needed.
  • If the point-of-care ELISA can be validated for accuracy in further studies, it could be a useful tool for rapid assessment of disease prevalence in horse populations.
  • Understanding the prevalence of these diseases assists in implementing measures to control and prevent these emerging risks.

Cite This Article

APA
Schvartz G, Epp T, Burgess HJ, Chilton NB, Pearl DL, Lohmann KL. (2015). Seroprevalence of equine granulocytic anaplasmosis and lyme borreliosis in Canada as determined by a point-of-care enzyme-linked immunosorbent assay (ELISA). Can Vet J, 56(6), 575-580.

Publication

The Canadian veterinary journal = La revue veterinaire canadienne
ISSN: 0008-5286
NlmUniqueID: 0004653
Country: Canada
Language: English
Volume: 56
Issue: 6
Pages: 575-580

Researcher Affiliations

Schvartz, Gili
  • Department of Large Animal Clinical Sciences (Schvartz, Epp, Lohmann), Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, and Department of Biology (Chilton), University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Department of Population Medicine, Ontario Veterinary College, University of Guelph, 50 Stone Road, Guelph, Ontario N1G 2W1 (Pearl).
Epp, Tasha
  • Department of Large Animal Clinical Sciences (Schvartz, Epp, Lohmann), Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, and Department of Biology (Chilton), University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Department of Population Medicine, Ontario Veterinary College, University of Guelph, 50 Stone Road, Guelph, Ontario N1G 2W1 (Pearl).
Burgess, Hilary J
  • Department of Large Animal Clinical Sciences (Schvartz, Epp, Lohmann), Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, and Department of Biology (Chilton), University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Department of Population Medicine, Ontario Veterinary College, University of Guelph, 50 Stone Road, Guelph, Ontario N1G 2W1 (Pearl).
Chilton, Neil B
  • Department of Large Animal Clinical Sciences (Schvartz, Epp, Lohmann), Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, and Department of Biology (Chilton), University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Department of Population Medicine, Ontario Veterinary College, University of Guelph, 50 Stone Road, Guelph, Ontario N1G 2W1 (Pearl).
Pearl, David L
  • Department of Large Animal Clinical Sciences (Schvartz, Epp, Lohmann), Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, and Department of Biology (Chilton), University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Department of Population Medicine, Ontario Veterinary College, University of Guelph, 50 Stone Road, Guelph, Ontario N1G 2W1 (Pearl).
Lohmann, Katharina L
  • Department of Large Animal Clinical Sciences (Schvartz, Epp, Lohmann), Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, and Department of Biology (Chilton), University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; Department of Population Medicine, Ontario Veterinary College, University of Guelph, 50 Stone Road, Guelph, Ontario N1G 2W1 (Pearl).

MeSH Terms

  • Anaplasmosis / blood
  • Anaplasmosis / epidemiology
  • Animals
  • Canada / epidemiology
  • Enzyme-Linked Immunosorbent Assay / methods
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Horse Diseases / blood
  • Horse Diseases / epidemiology
  • Horses
  • Lyme Disease / blood
  • Lyme Disease / epidemiology
  • Lyme Disease / veterinary
  • Point-of-Care Systems
  • Sensitivity and Specificity
  • Seroepidemiologic Studies

References

This article includes 49 references
  1. Foley JE, Foley P, Brown RN, Lane RS, Dumler JS, Madigan JE. Ecology of Anaplasma phagocytophilum and Borrelia burgdorferi in the western United States.. J Vector Ecol 2004;29:41–50.
    pubmed: 15266739
  2. Dumler JS, Barbet AF, Bekker CP. Reorganization of the genera of the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: Unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila.. Int J Syst Evol Microbiol 2001;51:2145–2165.
    pubmed: 11760958
  3. Rudenko N, Golovchenko M, Grubhoffer L, Oliver HJ. Updates on Borrelia burgdorferi sensu lato complex with respect to public health.. Ticks Tick Borne Dis 2011;2:123–128.
    pmc: PMC3167092pubmed: 21890064
  4. Schnarr S, Franz JK, Krause A, Zeidler H. Infection and musculo-skeletal conditions: Lyme borreliosis.. Best Pract Res Clin Rheumatol 2006;20:1099–1118.
    pubmed: 17127199
  5. Villeneuve A, Goring J, Marcotte L, Overvelde S. Seroprevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, Ehrlichia canis, and Dirofilaria immitis among dogs in Canada.. Can Vet J 2011;52:527–530.
    pmc: PMC3078009pubmed: 22043075
  6. Sperling J, Middelveen M, Klein D, Sperling F. Evolving perspectives on Lyme borreliosis in Canada.. Open Neurol J 2012;6:94–103.
    pmc: PMC3474999pubmed: 23091570
  7. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease — United States, 1992–2006.. MMWR Surveill Summ 2008;57:1–9.
    pubmed: 18830214
  8. Little SE, Heise SR, Blagburn BL, Callister SM, Mead PS. Lyme borreliosis in dogs and humans in the USA.. Trends Parasitol 2010;26:213–218.
    pubmed: 20207198
  9. Butler CM, Houwers DJ, Jongejan F, van der Kolk JH. Borrelia burgdorferi infections with special reference to horses. A review.. Vet Q 2002;27:146–156.
    pubmed: 16402512
  10. Jin H, Wei F, Liu Q, Qian J. Epidemiology and control of human granulocytic anaplasmosis: A systematic review.. Vector Borne Zoonotic Dis 2012;12:269–274.
    pubmed: 22217177
  11. Carrade DD, Foley JE, Borjesson DL, Sykes JE. Canine granulocytic anaplasmosis: A review.. J Vet Intern Med 2009;23:1129–1141.
    pubmed: 19761477
  12. Madigan JE. Equine ehrlichiosis.. Vet Clin North Am Equine Pract 1993;9:423–428.
    pubmed: 8358654
  13. Madigan JE, Gribble D. Equine ehrlichiosis in northern California: 49 cases (1968–1981). J Am Vet Med Assoc 1987;190:445–448.
    pubmed: 3558086
  14. Sellon DC. Disorders of the hematopoietic system.. In: Reed MS, Bayly WM, Sellon DC, editors. Equine Internal Medicine. 2nd ed. St. Louis, Missouri: Saunders; 2003. pp. 745–746.
  15. Divers T, Mair T, Chang Y. Lyme disease in horses.. In: Mair T, Hutchinson R, editors. Infectious Disease of the Horse. Cambridgeshire, UK: Equine Veterinary Journal; 2009. pp. 286–292.
  16. Bushmich SL. Lyme borreliosis in domestic animals.. J Spirochetal Tick Borne Dis 1994;1:24–28.
  17. Priest H, Irby N, Schlafer D. Diagnosis of Borrelia-associated uveitis in 2 horses.. Vet Ophthalmol 2012;15:398–405.
    pubmed: 22360730
  18. Imai DM, Barr BC, Daft B. Lyme neuroborreliosis in 2 horses.. Vet Pathol 2011;48:1151–1157.
    pubmed: 21285382
  19. James FM, Engiles JB, Beech J. Meningitis, cranial neuritis, and radiculoneuritis associated with Borrelia burgdorferi infection in a horse.. J Am Vet Med Assoc 2010;237:1180–1185.
    pubmed: 21073390
  20. Sears KP, Divers TJ, Neff RT, Miller WH Jr, McDonough SP. A case of Borrelia-associated cutaneous pseudolymphoma in a horse.. Vet Dermatol 2012;23:153–156.
    pubmed: 22029872
  21. Uehlinger FD, Clancey NP, Lofstedt J. Granulocytic anaplasmosis in a horse from Nova Scotia caused by infection with Anaplasma phagocytophilum.. Can Vet J 2011;52:537–540.
    pmc: PMC3078012pubmed: 22043078
  22. Burgess H, Chilton NB, Krakowetz CN, Williams C, Lohmann K. Granulocytic anaplasmosis in a horse from Saskatchewan.. Can Vet J 2012;53:886–888.
    pmc: PMC3398529pubmed: 23372198
  23. Berrington A, Moats R, Lester S. A case of Ehrlichia equi in an adult horse in British Columbia.. Can Vet J 1996;37:174–175.
    pmc: PMC1576643pubmed: 8681291
  24. Bourque J, Goltz J. Equine granulocytic anaplasmosis in a New Brunswick horse.. Proc 11th Annual Meeting of the Canadian Animal Health Laboratorians Network (CAHLN) Winnipeg, Manitoba. June 3–6, 2012; p. 40.
  25. Burgess B. British Columbia. Lyme disease in horses.. Can Vet J 1988;29:393–394.
    pmc: PMC1680893pubmed: 17423037
  26. Ogden NH, Mechai SMG. Changing geographic ranges of ticks and tick-borne pathogens: Drivers, mechanisms and consequences for pathogen diversity.. Front Cell Infect Microbiol 2013;3:46.
    pmc: PMC3756306pubmed: 24010124
  27. Ogden NH, Bouchard C, Kurtenbach K. Active and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in Canada.. Environ Health Perspect 2010;118:909–914.
    pmc: PMC2920908pubmed: 20421192
  28. Ogden NH, Lindsay LR, Hanincová K. Role of migratory birds in introduction and range expansion of Ixodes scapularis ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada.. Appl Environ Microbiol 2008;74:1780–1790.
    pmc: PMC2268299pubmed: 18245258
  29. Ogden NH, Trudel L, Artsob H. Ixodes scapularis ticks collected by passive surveillance in Canada: Analysis of geographic distribution and infection with Lyme borreliosis agent Borrelia burgdorferi.. J Med Entomol 2006;43:600–609.
    pubmed: 16739422
  30. Ogden NH, St-Onge L, Barker IK. Risk maps for range expansion of the Lyme disease vector, Ixodes scapularis, in Canada now and with climate change.. Int J Health Geogr 2008;7:24.
    pmc: PMC2412857pubmed: 18498647
  31. Ogden NH, Bigras-Poulin M, O’Callaghan CJ. A dynamic population model to investigate effects of climate on geographic range and seasonality of the tick Ixodes scapularis.. Int J Parasitol 2005;35:375–389.
    pubmed: 15777914
  32. Ogden NH, Maarouf A, Barker IK. Climate change and the potential for range expansion of the Lyme disease vector Ixodes scapularis in Canada.. Int J Parasitol 2006;36:63–70.
    pubmed: 16229849
  33. Chapman S, Bakken JS, Folk SM. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis — United States: A practical guide for physicians and other health-care and public health professionals.. MMWR Recomm Rep 2006;55:1–27.
    pubmed: 16572105
  34. Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.. MMWR Morb Mortal Wkly Rep 1995;44:590–591.
    pubmed: 7623762
  35. Wagner B, Goodman LB, Rollins A, Freer HS. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.. Equine Vet J 2013;45:533–537.
    pubmed: 23432019
  36. Chandrashekar R, Daniluk D, Moffitt S, Lorentzen L, Williams J. Serologic diagnosis of equine borreliosis: Evaluation of an in-clinic enzyme-linked immunosorbent assay (SNAP® 4Dx®). Int J Appl Res Vet Med 2008;6:145–150.
  37. Landis R, Koch GG. The measurement of observer agreement for categorical data.. Biometrics 1977;33:159–174.
    pubmed: 843571
  38. Bullock PM, Ames TR, Robinson RA, Greig B, Mellencamp MA, Dumler JS. Ehrlichia equi infection of horses from Minnesota and Wisconsin: Detection of seroconversion and acute disease investigation.. J Vet Intern Med 2000;14:252–257.
    pubmed: 10830537
  39. Marcus L, Patterson M, Gilfillan R, Urband P. Antibodies to Borrelia burgdorferi in New England horse: Serologic survey.. Am J Vet Res 1985;46:2570–2571.
    pubmed: 4083595
  40. Magnarelli LA, Ijdo JW, Van Andel AE, Wu C, Padula SJ, Fikrig E. Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the northeastern United States.. J Am Vet Med Assoc 2000;217:1045–1050.
    pubmed: 11019714
  41. Cohen D, Bosler EM, Bernard W, Meirs IID, Eisner R, Schulze TL. Epidemiologic studies of Lyme disease in horses and their public health significance.. Ann N Y Acad Sci 1988;539:244–257.
    pubmed: 3190097
  42. Durrani AZ, Goyal SM. Seroprevalence of Borrelia burgdorferi in horses in Minnesota.. J Anim Plant Sci 2011;21:8–11.
  43. Dibernardo A, Cote T, Ogden NH, Lindsay RL. The prevalence of Borrelia miyamotoi infection, and co-infection with other Borrelia spp. in Ixodes scapularis ticks collected in Canada.. Parasit Vectors 2014;7:183.
    pmc: PMC4001108pubmed: 24731287
  44. Leighton PA, Koffi JK, Pelcat Y, Lindsay LR, Ogden NH. Predicting the speed of tick invasion: An empirical model of range expansion for the Lyme disease vector Ixodes scapularis in Canada.. J Appl Ecol 2012;49:457–464.
  45. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa.. J Clin Epidemiol 1993;46:423–429.
    pubmed: 8501467
  46. Sim J, Wright CC. The kappa statistic in reliability studies: Use, interpretation, and sample size requirements.. Phys Ther 2005;85:257–268.
    pubmed: 15733050
  47. Marques AR. Lyme Disease: A Review.. Curr Allergy Asthma Rep 2010;10:13–20.
    pubmed: 20425509
  48. Liang FT, Jacobson RH, Straubinger RK, Grooters A, Philipp MT. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.. J Clin Microbiol 2000;38:4160–4166.
    pmc: PMC87557pubmed: 11060084
  49. Franzén P, Aspan A, Egenvall A, Gunnarsson A, Aberg L, Pringle J. Acute clinical, hematologic, serologic, and polymerase chain reaction findings in horses experimentally infected with a European strain of Anaplasma phagocytophilum.. J Vet Intern Med 2005;19:232–239.
    pubmed: 15822569

Citations

This article has been cited 2 times.
  1. Rule EK, Boyle AG, Stefanovski D, Anis E, Linton J, Lorello O. Transfer of naturally acquired specific passive immunity against Anaplasma phagocytophilum in foals in Southeastern Pennsylvania and Northern Maryland. J Vet Intern Med 2023 Sep-Oct;37(5):1889-1892.
    doi: 10.1111/jvim.16812pubmed: 37515307google scholar: lookup
  2. Velayudhan BT, Naikare HK. Point-of-care testing in companion and food animal disease diagnostics. Front Vet Sci 2022;9:1056440.
    doi: 10.3389/fvets.2022.1056440pubmed: 36504865google scholar: lookup
Subscribe to our newsletter
Join 100,127 horse owners like you who receive our email updates on horse health and nutrition.